Pharmacogenomics can improve antipsychotic treatment in schizophrenia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenomics can improve antipsychotic treatment in schizophrenia
Authors
Keywords
pharmacogenomics, epigenetics, schizophrenia, antipsychotics
Journal
Frontiers of Medicine
Volume 7, Issue 2, Pages 180-190
Publisher
Springer Nature
Online
2013-04-21
DOI
10.1007/s11684-013-0249-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antipsychotics and Schizophrenia: From Efficacy and Effectiveness to Clinical Decision-Making
- (2017) George Foussias et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Neurocognition and neuroimaging of persistent negative symptoms of schizophrenia
- (2012) Cindy L Hovington et al. Expert Review of Neurotherapeutics
- Pharmacogenomic Associations With Weight Gain in Olanzapine Treatment of Patients Without Schizophrenia
- (2012) John P. Houston et al. JOURNAL OF CLINICAL PSYCHIATRY
- Pharmacogenomics of CYP2D6: Molecular Genetics, Interethnic Differences and Clinical Importance
- (2011) Lay Kek Teh et al. Drug Metabolism and Pharmacokinetics
- A systematic review of meta-analyses of the efficacy of oral atypical antipsychotics for the treatment of adult patients with schizophrenia
- (2011) Leslie Citrome EXPERT OPINION ON PHARMACOTHERAPY
- Evidence-based pharmacotherapy of schizophrenia
- (2011) Stefan Leucht et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Effect of cytochrome P450 3A4 inhibitor ketoconazole on risperidone pharmacokinetics in healthy volunteers
- (2011) W. Mahatthanatrakul et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2
- (2011) Wei-Hua Yue et al. NATURE GENETICS
- Common variants on 8p12 and 1q24.2 confer risk of schizophrenia
- (2011) Yongyong Shi et al. NATURE GENETICS
- Functional consequences of twoHTR2Cpolymorphisms associated with antipsychotic-induced weight gain
- (2011) Matthew J Hill et al. PHARMACOGENOMICS
- Adjunct Mirtazapine for Negative Symptoms of Schizophrenia
- (2011) Stephanie V Phan et al. PHARMACOTHERAPY
- Influence of DRD2 polymorphisms on the clinical outcomes of patients with schizophrenia
- (2011) Zalina Zahari et al. PSYCHIATRIC GENETICS
- Pharmacogenomics of antipsychotics efficacy for schizophrenia
- (2011) Ramón Cacabelos et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Effectiveness of maintenance treatments with atypical and typical antipsychotics in stable schizophrenia with early stage: 1-year naturalistic study
- (2011) Xiaofeng Guo et al. PSYCHOPHARMACOLOGY
- Efficacy of atypical v. typical antipsychotics in the treatment of early psychosis: meta-analysis
- (2010) Nicolas A. Crossley et al. BRITISH JOURNAL OF PSYCHIATRY
- The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naïve patients with first-episode schizophrenia treated with risperidone
- (2010) Nikolina Jovanović et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure—an impact similar to male gender or smoking in schizophrenic patients
- (2010) Roza Ghotbi et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction
- (2010) Jian-Ping Zhang et al. Expert Opinion on Drug Metabolism & Toxicology
- Effect of CYP2D6, CYP3A5, and MDR1 Genetic Polymorphisms on the Pharmacokinetics of Risperidone and Its Active Moiety
- (2010) Qian Xiang et al. JOURNAL OF CLINICAL PHARMACOLOGY
- High Correlation Between Serum and Cerebrospinal Fluid Olanzapine Concentrations in Patients With Schizophrenia or Schizoaffective Disorder Medicating With Oral Olanzapine as the Only Antipsychotic Drug
- (2010) Elisabeth Skogh et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs
- (2010) D E Adkins et al. MOLECULAR PSYCHIATRY
- The Path to Personalized Medicine
- (2010) Margaret A. Hamburg et al. NEW ENGLAND JOURNAL OF MEDICINE
- The past, present and future of pharmacoepigenomics
- (2010) Magnus Ingelman-Sundberg et al. PHARMACOGENOMICS
- Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia
- (2010) M R Kuzman et al. PHARMACOGENOMICS JOURNAL
- Effect of second-generation antipsychotics on cognition: current issues and future challenges
- (2009) S Kristian Hill et al. Expert Review of Neurotherapeutics
- Association Between HTR2C and HTR2A Polymorphisms and Metabolic Abnormalities in Patients Treated With Olanzapine or Clozapine
- (2009) Arzu Gunes et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients
- (2009) J. Du et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics
- (2009) J L McClay et al. MOLECULAR PSYCHIATRY
- Association between a polymorphism of the HTR3A gene and therapeutic response to risperidone treatment in drug-naive Chinese schizophrenia patients
- (2009) Bo Gu et al. Pharmacogenetics and Genomics
- ABCB1polymorphisms are associated with clozapine plasma levels in psychotic patients
- (2009) Giorgio Consoli et al. PHARMACOGENOMICS
- Association analysis of serotonin receptor 7 gene (HTR7) and risperidone response in Chinese schizophrenia patients
- (2009) Zhiyun Wei et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- A case–control association study between the CYP3A4 and CYP3A5 genes and schizophrenia in the Chinese Han population
- (2009) Jing Du et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Excess of transmission of the G allele of the -1438A/G polymorphism of the 5-HT2Areceptor gene in patients with schizophrenia responsive to antipsychotics
- (2008) Dalila Benmessaoud et al. BMC Psychiatry
- The —1019 C/G polymorphism of the 5-HT1A receptor gene is associated with negative symptom response to risperidone treatment in schizophrenia patients
- (2008) L. Wang et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Perceiving is believing: a Bayesian approach to explaining the positive symptoms of schizophrenia
- (2008) Paul C. Fletcher et al. NATURE REVIEWS NEUROSCIENCE
- Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia
- (2008) Masashi Ikeda et al. PHARMACOGENOMICS
- DRD4 48 bp VNTR but not 5-HT2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain
- (2008) J Popp et al. PHARMACOGENOMICS JOURNAL
- Subjective Symptoms of Schizophrenia in Research and the Clinic: The Basic Symptom Concept
- (2008) F. Schultze-Lutter SCHIZOPHRENIA BULLETIN
- Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: A retrospective chart review
- (2008) Marc De Hert et al. SCHIZOPHRENIA RESEARCH
- ABCB1 Polymorphisms Influence Steady-State Plasma Levels of 9-Hydroxyrisperidone and Risperidone Active Moiety
- (2008) Arzu Gunes et al. THERAPEUTIC DRUG MONITORING
- Cytochrome P450 and Chemical Toxicology
- (2007) F. Peter Guengerich CHEMICAL RESEARCH IN TOXICOLOGY
- Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting
- (2007) Malin Alenius et al. JOURNAL OF PSYCHIATRIC RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now